Precision BioSciences Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
Precision BioSciences, Inc. income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Revenue & Gross Profit
Revenue68.7048.7325.10115.5324.2922.24
Cost of Revenue0.000.000.000.000.000.00
Gross Profit68.7048.7325.10115.5324.2922.24
Operating Expenses
Research & Development59.5653.3844.07115.2494.7182.42
Selling, General & Administrative35.3039.0943.3439.6739.4127.03
Operating Expenses94.8692.4687.41154.91134.11109.44
Operating Income-26.16-43.74-62.31-39.38-109.83-87.20
Other Income/Expense
Interest Income6.767.693.470.210.820.00
Interest Expense-1.78-2.23-1.11-0.130.000.00
Other Income/Expense29.614.252.20-8.700.159.76
Income
Income Before Tax7.17-42.53-72.91-30.60-109.01-92.88
Income Tax Expense0.00-1.77-3.00-0.84-1.311.83
Net Income7.17-61.32-111.64-30.60-109.01-92.88
Net Income - Continuous Operations7.17-42.53-72.91-30.600.000.00
Net Income - Discontinued Operations0.00-18.79-38.730.000.000.00
EBITDA-22.76-36.92-54.51-20.27-101.05-87.38
EBIT-26.16-43.74-62.31-30.47-109.83-92.70
Depreciation & Amortization3.406.827.808.988.78-5.32
Earnings Per Share
Basic EPS1.00-16.00-38.00-16.00-63.00-
Diluted EPS1.00-16.00-38.00-16.00-63.00-2.00
Basic Shares Outstanding6.833.842.931.961.7341.99
Diluted Shares Outstanding6.883.842.931.961.7341.99